Priority: Impact of rHuEPO on CKD Anemia Care

H2 tag- SEO Purpose

Priority: Impact of rHuEPO on CKD Anemia Care

Is rHuEPO therapy good for CKD Anemia?Is rHuEPO therapy good for CKD Anemia?
Adverse effects of eHUEPO therapy in renal anemiaAdverse effects of eHUEPO therapy in renal anemia
Non-haematologic complications in erythropoietin therapyNon-haematologic complications in erythropoietin therapy
rHUEPO effective strategy with potential side effectsrHUEPO effective strategy with potential side effects

Abbreviations

CKD: Chronic kidney disease; rHuEPO: Recombinant human erythropoietin.

References

1. Garrido P, Ribeiro S, Fernandes J, et al. Resistance to recombinant human erythropoietin therapy in a rat model of chronic kidney disease associated anemia. Int J Mol Sci. 2016;17(1):28. 2. Katagiri D, Hinoshita F. Benefits and risks of erythrocyte-stimulating agents. World J Clin Urol. 2014;3(3):258–263.

LMRC Code: GGI-CO-A1-AQS-300027678-BANNERS-G24-0782

.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cresp

 Cresp®(Biosimilar of darbepoetin alpha), a product by Dr. Reddy's is an erythropoiesis-stimulating agent which helps in treatment of renal anemia in pre-dialysis patients

Cresp